Parallax Volatility Advisers’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-33,947
Closed -$324K 1613
2025
Q3
$304K Buy
+33,947
New +$314K ﹤0.01% 1321
2025
Q1
Sell
-149,638
Closed -$1.51M 1531
2024
Q4
$1.42M Buy
149,638
+142,424
+1,974% +$1.44M ﹤0.01% 1232
2024
Q3
$81K Sell
7,214
-58,953
-89% -$627K ﹤0.01% 1792
2024
Q2
$662K Buy
+66,167
New +$672K ﹤0.01% 1376
2024
Q1
Sell
-10,000
Closed -$72.9K 1785
2023
Q4
$72.9K Sell
10,000
-104,047
-91% -$820K ﹤0.01% 1890
2023
Q3
$1.04M Buy
+114,047
New +$1.37M ﹤0.01% 1352
2023
Q1
Sell
-42,731
Closed -$786K 2671
2022
Q4
$821K Buy
+42,731
New +$903K ﹤0.01% 1726

Other funds holding AHCO

Parallax Volatility Advisers's AHCO Position: Q4 2025 in Review

Parallax Volatility Advisers sold out of AdaptHealth (AHCO) in Q4 2025, closing a stake of 33,947 shares — an estimated $324K sold.

Parallax Volatility Advisers first reported a position in AHCO in Q4 2022 and held it in 7 quarters. The position peaked at $1.42M in Q4 2024. 231 funds tracked by Wall St. Rank hold AHCO as of Q4 2025.

  • Parallax Volatility Advisers reported no remaining AdaptHealth position as of Q4 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 33,947 AdaptHealth shares in Q4 2025, an estimated $324K.
  • Parallax Volatility Advisers first reported a position in AdaptHealth in Q4 2022 and held it in 7 quarters.
  • Parallax Volatility Advisers's AdaptHealth position peaked at $1.42M in Q4 2024.
  • 231 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2025.

Based on Parallax Volatility Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.